The State Administration of Drug Regulation announces an extension of the protection period for Huperzine A drops.

The State Drug Administration issued Announcement No. 89 of 2025, in accordance with the provisions of Article 16 of the Regulations on the Protection of Traditional Chinese Medicine Varieties and related regulations. After the evaluation by the members organized by the National Traditional Chinese Medicine Variety Protection Evaluation Committee, it was decided to continue to grant second-level protection to the Dendrobium candidum pill of Nanchang Hongyi Pharmaceutical Co., Ltd., with a protection period from September 10, 2025 to February 25, 2032.